Evidence map›Paper›PMID 21799074›Full record

ArticleAmerican journal of respiratory and critical care medicine2011

DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer.

Robert A A van Boerdonk, Thomas G Sutedja, Peter J F Snijders, Emilie Reinen, Saskia M Wilting, Mark A van de Wiel, F Erik B J M Thunnissen, Sylvia Duin, Clarissa Kooi, Bauke Ylstra and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. FocalThoracic cancer · 2023
    Article
  7. The European respiratory journal · 2022
    Article
  8. Article
  9. Article
  10. Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Robert A A van BoerdonkVU University Medical Center, Department of Pathology, De Boelelaan 1117, Amsterdam, The Netherlands.
Thomas G Sutedja
Peter J F Snijders
Emilie Reinen
Saskia M Wilting
Mark A van de Wiel
F Erik B J M Thunnissen
Sylvia Duin
Clarissa Kooi
Bauke Ylstra
Chris J L M Meijer
Gerrit A Meijer
Katrien Grünberg
Johannes M A Daniels
Pieter E Postmus
Egbert F Smit
Daniëlle A M Heideman
Pulmonary Associates · USAmsterdam UMC Location Vrije Universiteit Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleAutofluorescence bronchoscopy (AFB) is a valid strategy for detecting premalignant endobronchial lesions. However, no biomarker can reliably predict lung cancer risk of subjects with AFB-visualized premalignant lesions.

objectivesThe present study set out to identify AFB-visualized squamous metaplastic (SqM) lesions with malignant potential by DNA copy number profiling.

methodsRegular AFB examinations in 474 subjects at risk of lung cancer identified six subjects with SqM lesions at baseline, and carcinoma in situ or carcinoma (carcinoma in situ or greater) at the initial SqM site at follow-up bronchoscopy. These progressive SqM lesions were compared for immunostaining pattern and array comparative genomic hybridization-based chromosomal profiles with 23 SqM lesions of subjects who remained cancer-free. Specific DNA copy number alterations (CNAs) linked to cancer risk were identified and accuracy of CNAs to predict endobronchial cancer in this series was determined. MEASUREMENTS AND MAIN

resultsAt baseline, p53, p63, and Ki-67 immunostaining were not predictive for a differential clinical outcome of SqM lesions. The mean number of CNAs in baseline SqM of cases was significantly higher compared with control subjects (P < 0.01). Chromosomal regions significantly more frequently altered in SqM of cases were 3p26.3-p11.1, 3q26.2-q29, 9p13.3-p13.2, and 17p13.3-p11.2 (family-wise error rate <0.10). CNAs were specifically detected at the site of future cancer. In cases, baseline-detected CNAs persisted in subsequent biopsies taken from the initial site, and levels increased toward cancer progression. In this series, a model based on CNAs at 3p26.3-p11.1, 3q26.2-29, and 6p25.3-24.3 predicted cancer with 97% accuracy.

conclusionsThe data suggest that the presence of specific CNAs in SqM lesions predict endobronchial cancer.

Indexed as

DNA Copy Number VariationsGenetic MarkersAgedBiopsyBronchoscopyCarcinoma in SituCarcinoma, Squamous CellCase-Control StudiesCohort StudiesFemaleHumansLung NeoplasmsMaleMetaplasiaMiddle AgedRiskGenetic Markers

Identifiers

PMID21799074
OpenAlexW2091283166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.